In a vaccine research study, people help doctors find ways to improve health. Each vaccine research study seeks to answer specific scientific questions and find better ways to prevent disease. Vaccines have to go through research studies before they can be approved for public use. A vaccine research study follows a plan that is reviewed and approved before it can begin. This review ensures that the research study follows safety guidelines.
Vaccine research studies are important, because they help us understand whether a potential vaccine may provide different coverage and protection to vaccines we use now. We can also learn what the benefits and risks are.
About the NeXXstep 14 Study
The NeXXstep 14 Study is a vaccine research study for children/teens, which will evaluate an investigational pneumococcal vaccine. We want to learn about the safety and protection of the investigational vaccine.
What is the investigational vaccine?
The investigational vaccine contains the same base ingredients as an approved pneumococcal vaccine, but it targets 20 types of pneumococcal germs instead of 13.
It will be given by injection into the leg if your child is aged 15 to 23 months, or into the arm if your child/teen is aged 2 to 17 years.
Everyone who takes part in the NeXXstep 14 Study will receive just one dose of the investigational vaccine.
Are there any risks or benefits to taking part?
You will have the chance to review with the study team the most likely risks or discomforts expected from this study before agreeing to have your child/teen participate.
The health and well-being of every child/teen that takes part will be monitored. What we learn from the NeXXstep Study may benefit children/teens in the future, by reducing the risk of pneumococcal disease.